Lanoxin and Diphen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanoxin (digoxin) and Diphen (diphenhydramine hydrochloride). Common drug interactions include aspartate aminotransferase increased among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Lanoxin and Diphen. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.



On Jul, 20, 2026

57 people who take Lanoxin and Diphen together, and have interactions are studied.

Lanoxin and Diphen drug interactions.

What are the common drug interactions of Lanoxin and Diphen, by gender? *:

female:

  1. Aspartate aminotransferase increased
  2. Asthenia (weakness)
  3. Asthma
  4. Blood creatinine increased
  5. Blood lactic acid increased
  6. Blood magnesium decreased
  7. Blood potassium decreased
  8. Blood pressure decreased
  9. Blood sodium decreased
  10. Blood uric acid increased

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Arrhythmia (irregular heartbeat)
  3. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  4. Hepatic failure (liver failure)
  5. Liver disorder (liver diseases)
  6. Pneumonia
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Septic shock (shock due to blood infection)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Lanoxin and Diphen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac arrest
  2. Dysstasia (difficulty in standing)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Cough
  6. Depression
  7. Disability
  8. Fear
  9. Infection
  10. Injury

50-59:

  1. Hepatic failure (liver failure)
  2. Liver disorder (liver diseases)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Septic shock (shock due to blood infection)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Serratia bacteraemia (bacterial blood infection)
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)
  3. Sinusitis (inflammation of sinus)
  4. Urine flow decreased
  5. Asthenia (weakness)
  6. Back pain
  7. Blood pressure decreased
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 14.04%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 8.77%
  3. Type 2 Diabetes: 3 people, 5.26%
  4. Pain: 3 people, 5.26%
  5. Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 5.26%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and Diphen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lanoxin and Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lanoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diphen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and diphenhydramine hydrochloride (the active ingredients of Lanoxin and Diphen, respectively), and Lanoxin and Diphen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: